共 50 条
- [41] Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction - Results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT) CIRCULATION, 2005, 112 (22) : 3391 - 3399
- [42] In-hospital adherence to current guidelines is not optimal for antiplatelet and antithrombotic therapies in patients with acute myocardial infarction: Insights from the international valsartan in acute myocardial infarction (VALIANT) registry JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 251A - 252A
- [46] Risk stratification following acute myocardial infarction ZEITSCHRIFT FUR KARDIOLOGIE, 2000, 89 : 75 - 86
- [48] DIABETES FOLLOWING MYOCARDIAL INFARCTION JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 166 (11): : 1408 - 1408
- [49] Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (09):
- [50] Renal dysfunction as a risk factor for painless myocardial infarction: results from Korea Acute Myocardial Infarction Registry Clinical Research in Cardiology, 2012, 101 : 795 - 803